Pazopanib for three patients with recurrence of retroperitoneal liposarcoma : initial clinical experience

Pazopanib, a novel tyrosine kinase inhibitor, is an effective therapeutic agent for patients with advanced soft tissue sarcoma. Here we report three patients with recurrent retroperitoneal liposarcoma who were treated with pazopanib. Case 1: A 54-year-old male received three courses of combined chem...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Hinyokika kiyo. Acta urologica Japonica. - 1962. - 61(2015), 4 vom: 23. Apr., Seite 153-8
1. Verfasser:	Koizumi, Atsushi (VerfasserIn)
Weitere Verfasser:	Inoue, Takamitsu, Takayama, Koichiro, Takahashi, Makoto, Numakura, Kazuyuki, Tsuruta, Hiroshi, Akihama, Susumu, Saito, Mitsuru, Narita, Shintaro, Tsuchiya, Norihiko, Satoh, Shigeru, Habuchi, Tomonori
Format:	Aufsatz
Sprache:	Japanese
Veröffentlicht:	2015
Zugriff auf das übergeordnete Werk:	Hinyokika kiyo. Acta urologica Japonica
Schlagworte:	Case Reports Journal Article Angiogenesis Inhibitors Indazoles Pyrimidines Sulfonamides pazopanib 7RN5DR86CK